Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 1/2006

Content (19 Articles)

Original Article

Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone

Richard D. Verschoyle, Peter Greaves, Hong Cai, Arndt Borkhardt, Massimo Broggini, Maurizio D’Incalci, Ed Riccio, Rupa Doppalapudi, Izet M. Kapetanovic, William P. Steward, Andreas J. Gescher

Original Article

Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes

Ann M. Straight, Kevin Oakley, Russell Moores, Andrew J. Bauer, Aneeta Patel, R. Michael Tuttle, J. Jimeno, Gary L. Francis

Original Article

Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors

Carlos Rodriguez-Galindo, Kristine R. Crews, Clinton F. Stewart, Wayne Furman, J. Carl Panetta, Najat C. Daw, Alvida Cain, Ming Tan, Peter H. Houghton, Victor M. Santana

Original Article

GBP1 overexpression is associated with a paclitaxel resistance phenotype

Zhenfeng Duan, Rosemary Foster, Katherine A. Brakora, Rushdia Z. Yusuf, Michael V. Seiden

Original Article

Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours

Michele Caraglia, Raffaele Addeo, Raffaele Costanzo, Liliana Montella, Vincenzo Faiola, Monica Marra, Alberto Abbruzzese, Giovannella Palmieri, Alfredo Budillon, Francesco Grillone, Salvatore Venuta, Pierosandro Tagliaferri, Salvatore Del Prete

Original Article

Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy

David A. Bellnier, William R. Greco, Hector Nava, Gregory M. Loewen, Allan R. Oseroff, Thomas J. Dougherty

Original Article

Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients

Gianfilippo Bertelli, Abdelhamid Heouaine, Giuseppe Arena, Ambrogio Botto, Ornella Garrone, Ida Colantonio, Marcella Occelli, Elena Fea, Silvia Giubergia, Marco Merlano

Original Article

Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study

Alessandra Felici, Paolo Carlini, Enzo Maria Ruggeri, Teresa Gamucci, Camillo Franco Pollera, Salvatore De Marco, Anna Maria Fariello, Luca Moscetti, Alain Gelibter, Ennio Adami, Isabella Sperduti, Francesco Cognetti

Original Article

Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo

V. Kirveliene, G. Grazeliene, D. Dabkeviciene, I. Micke, D. Kirvelis, B. Juodka, J. Didziapetriene

Original Article

Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia

Hans Minderman, Kieran L. O’Loughlin, Patrick F. Smith, Lakshmi Pendyala, William R. Greco, Kimberly G. Sweeney, Laurie A. Ford, Meir Wetzler, Maria R. Baer

Original Article

Role of Na+, K+-ATPase α1 subunit in the intracellular accumulation of cisplatin

Shuichi Kishimoto, Yuji Kawazoe, Mako Ikeno, Mizuha Saitoh, Yukari Nakano, Yuko Nishi, Shoji Fukushima, Yoshikazu Takeuchi

Original Article

Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer

Se Hoon Park, Jeeyun Lee, Se Hoon Lee, Joon Oh Park, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young Suk Park, Won Ki Kang, Keunchil Park, Seonwoo Kim, Soo Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee

Original Article

Study on brain targeting of raltitrexed following intranasal administration in rats

Dongxing Wang, Yongliang Gao, Liuhong Yun

Original Article

Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma

Jörgen Bierau, Albert H. van Gennip, René Leen, Rutger Meinsma, Huib N. Caron, André B. P. van Kuilenburg

Clinical Trial Report

Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer

Baoli Qin, Ken Kato, Kenji Mitsugi, Minoru Nakamura, Risa Tanaka, Eishi Baba, Hiroshi Ariyama, Toshiro Kuroiwa, Mine Harada, Shuji Nakano

Short Communication

Role of plasma lipids and lipoproteins in predicting amphotericin B-induced nephrotoxicity in pediatric oncology patients

Kishor M. Wasan, Joyce C. Wong, Traci Corr, Sheila Pritchard

Short Communication

Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone

Seppo W. Langer, Annemette V. Thougaard, Maxwell Sehested, Peter Buhl Jensen

Short Communication

Characterization of secretory intestinal transport of the lactone form of CPT-11

Isao Takemoto, Shirou Itagaki, Makoto Chiba, Tatsuya Itoh, Takeshi Hirano, Ken Iseki

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine